InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
0.8640
-0.0039 (-0.45%)
At close: Jul 18, 2025, 4:00 PM
0.9020
+0.0380 (4.40%)
After-hours: Jul 18, 2025, 6:48 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Monoclonal Antibodies
68.21K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
68.21K